Human Amniotic Mesenchymal Stem Cells-Derived IGFBP-3, DKK-3, and DKK-1 attenuate Liver Fibrosis through Inhibiting Hepatic Stellate Cell Activation by Blocking Wnt/β-Catenin Signaling Pathway in Mice

Human amniotic mesenchymal stem cells (hAMSCs) were transplanted into carbon tetrachloride (CCl4)-induced liver fibrosis mice via tail vein, and the effects of hAMSCs on hepatic fibrosis were assessed.